1. Home
  2. FNB vs LEGN Comparison

FNB vs LEGN Comparison

Compare FNB & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo F.N.B. Corporation

FNB

F.N.B. Corporation

HOLD

Current Price

$15.85

Market Cap

6.5B

Sector

Finance

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$18.76

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNB
LEGN
Founded
1864
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
5.9B
IPO Year
2001
2020

Fundamental Metrics

Financial Performance
Metric
FNB
LEGN
Price
$15.85
$18.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
13
Target Price
$19.10
$63.08
AVG Volume (30 Days)
7.0M
1.7M
Earning Date
04-22-2026
01-01-0001
Dividend Yield
2.99%
N/A
EPS Growth
22.83
N/A
EPS
1.56
N/A
Revenue
N/A
N/A
Revenue This Year
$14.53
$46.27
Revenue Next Year
$7.90
$28.77
P/E Ratio
$10.29
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.93
$16.24
52 Week High
$19.14
$45.30

Technical Indicators

Market Signals
Indicator
FNB
LEGN
Relative Strength Index (RSI) 28.46 49.02
Support Level $15.47 $17.46
Resistance Level $16.38 $23.68
Average True Range (ATR) 0.48 0.81
MACD -0.17 0.16
Stochastic Oscillator 1.88 47.10

Price Performance

Historical Comparison
FNB
LEGN

About FNB F.N.B. Corporation

F N B Corp provides a full range of financial services, principally to consumers, corporations, governments and small- to medium-sized businesses. It has three reportable business segments: Community Banking, Wealth Management and Insurance. The majority of revenue is from the Community banking segment. It offers commercial & consumer banking services. Commercial banking solutions include corporate banking, small business banking, investment real estate financing, business credit, capital markets & lease financing. Consumer banking products & services include deposit products, mortgage lending, & consumer lending & a complete suite of mobile & online banking services.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: